In clinical practice, physicians have recently attempted to avoid mechanical ventilation (MV) as much as possible and have started to use non-invasive ventilation (NIV) in patients with respiratory failure. A prospective observational study was conducted to assess the applicability, effectiveness, and safety of NIV in managing patients with respiratory failure in Palestine. Fiftytwo patients (39 patients from West Bank and 13 patients from Gaza Strip) who fulfilled criteria for inclusion were admitted to the two medical care units of the An-Najah National Teaching Hospital during a 10-month period. These patients formed the study population to receive NIV. The results came with baseline (mean ± SD) pH, PaO 2 , and PaCO 2 measurements of 7.36 ± 0.1, 75.62 ± 32.7, and 46.5 ± 20.86 mmHg, respectively. The primary indication for NIV was hypoxemic respiratory failure (n = 38, 73%). The success rate with NIV was 78%, with 40 out of 52 patients weaned successfully. Significant improvements were observed in the first hour following institution of NIV in pH (7.38 ± 0.07, P < 0.001), PaO 2 (90.4 ± 52.4, P < 0.001), and PaCO 2 (40.4 ± 12.6, P < 0.001). These physiological parameters continued to improve up to the time of weaning: pH (7.39 ± 0.07, P < 0.001), PaO 2 (99.9 ± 44.3, P < 0.001), and PaCO 2 (38.6 ± 13.9, P < 0.001). The parameters were maintained within 12 h post-weaning: pH (7.39 ± 0.08, P < 0.001), PaO 2 (97 ± 30.3, P < 0.001), and PaCO 2 (36.9 ± 10.3, P < 0.001). This study has shown benefits of NIV in avoiding the call for invasive MV in patients exhibiting respiratory failure of varied etiology, with similar results comparable to previous studies in developed countries. Thus,
increased usage of NIV in respiratory failure is likely to affect favorably in countries with limited resources such as Palestine.
Introduction
Respiratory failure is a common cause of illness and death, the cost to society in terms of lost productivity and shortened lives is enormous [1] . Mortality rates in Intensive Care Units (ICUs) in Europe were around 40% [2, 3] , and epidemiological studies suggest that respiratory failure will become more common as the population ages, increasing by as much as 80% in the next 20 years [1] .
For many years, patients who developed respiratory failure had to be put on invasive MV, but it caused many severe complications in those patients, so the recent critical care literature has shown an outburst of articles on non-invasive respiratory ventilation for patients with respiratory failure of varied etiology, with numerous published randomized controlled trials and meta-analysis on this topic [4] [5] [6] [7] [8] . Abundant data supporting NIV impact on respiratory failure have been published from the western countries [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , but hardly any data from the Middle East.
Also, Palestinian hospitals lack any experience with NIV, but the An-Najah National University teaching hospital has recently started to equip their critical care centers (Intensive Care Unit and Cardiac Care Unit) with non-invasive ventilator and well-trained teams with critical care specialists and has started dealing with patients from all over the West Bank and Gaza Strip including those who are referred by the ministry of health. This study evaluates the applicability, effectiveness, and safety of NIV as a first-line intervention for respiratory failure in this hospital. Also, we expect from this study to increase the awareness in Palestinian health society and the region of the NIV role in respiratory failure.
Subjects and methods
After approval by the local ethics committee of research institutions at the An-Najah National University, Nablus, Palestine (Chairperson Prof. Samar Musmar) on December 23, 2012, we enrolled patients with respiratory failure who were admitted to the two critical care units of An-Najah hospital from the West Bank and Gaza Strip during the period from January 2013 to November 2013. After obtaining written informed consent, the study sample consists of 52 patients with a mean age of 59.6 and male predominance of 57%.
The inclusion Criteria were (1) patient with respiratory failure with either [21] : (1) hypoxemic respiratory failure (type 1) defined by a PaO 2 of <60 mmHg or PaO 2 to FiO 2 ratio > 300 mmHg with a normal or low PaCO 2 , or (2) Hypercapnic respiratory failure (type 2) defined by a PaO 2 of <60 mmHg or PaO 2 to FiO 2 ratio > 300 mmHg and a PaCO 2 of >45 mmHg; (2) patient who had been on mechanical ventilation for a certain reason and need to be weaned from intubation. Furthermore, patients were divided into 7 diagnostic groups based on the condition that participate respiratory failure, see Table 1 .
Criteria for excluding patients from the study include: (1) Inability of the patient to protect the airway (coma or seizure disorders) requiring an endotracheal tube or to manage secretions;
(2) Systolic blood pressure less than 90 mmHg or use of vasopressors (shock); (3) Electrocardiogram instability with evidence of ischemia or ventricular arrhythmias; (4) Life-threatening hypoxemia (O 2 saturation < 80%, or PaCO 2 > 60 mmHg on a nonrebreathing face mask); (5) Agitation, lack of cooperation, facial trauma, burns, or facial surgery.
Criteria for failure and stop of NIV and exit from the study include: Development of conditions necessitating ETI, which include: (1) inability to increase or stabilize gas exchange, failure to improve agitation from hypoxemia for type 1 and/or hypercapnia for type 2 for 60 min; (2) hemodynamic or ECG instability: bradycardia (heart rate < 60 beats/min), hypotension (systolic blood pressure < 90 mmHg), and respiratory arrest; failure to maintain SpO 2 > 88%, significant metabolic and/or respiratory acidosis (pH < 7.20); (3) inability to tolerate the face mask because of discomfort; (4) failure to improve mental status within 60 min for the patient who was lethargic.
Procedures
The method of NIV is shown in Fig. 1 . In this study, we used the two main modalities of NIV: continuous positive airway pressure (CPAP) which was used for hypoxemic respiratory failure and bi-level positive air pressure (BIPAP) which was Table 1 Primary indication for NIV and diagnosis at admission; the total number adds up to more than 52 as some patients had more than one diagnosis and cause for respiratory failure. used for hypercapnic respiratory failure and for patients who were not improving sufficiently on CPAP alone. The ventilator (Puritan Bennett Co or Galileo) was connected with conventional ventilator tubing to a clear, full-face mask (Phillips; and Puritan Bennett Co) with two adult sizes: medium and large. First, to reduce the risk of aspiration, the head of the bed was raised to an angle of 45°and was kept elevated during NIV. Then, the full-face mask was softly placed over the patient's face and was kept in position by a nurse for a few minutes until the patient was comfortable and completely synchronized with the ventilator. The mask was then secured by head straps, avoiding a tight fit. Also, a tincture of benzoin was frequently smeared over the mask's cushion to favor sealing with the skin interface, in order to reduce air leakage. To reduce skin necrosis over the nasal bridge and at other contact sites and to seal air leaks, a skin patch was applied. Regarding nasogastric suction, it was only administrated if the patient was expected to develop gastric distention. After the mask had been placed, a CPAP of 5 cm H 2 O was applied and pressure support ventilation (PSV) was increased to achieve tidal volume of 5-7 ml/kg, a respiratory rate of less than 25 breaths/min, and patients relief until borderline 20 cm H 2 O. While with BIPAP, we started with 10 cm H 2 O inspiratory positive airway pressure (IPAP) and 5 cm H 2 O expiratory positive airway pressure (EPAP) with initial adjustments to obtain tidal volume of 5-7 ml/kg. After that, subsequent adjustments were based on arterial blood gas values with CPAP increased from 2 to 3 cm H 2 O until borderline 15 cm H 2 O; because it reduced venous return and patients with borderline low blood pressure can become hemodynamically unstable. While with BIPAP, if there is persistent hypercapnia, IPAP was increased by 2 cm H 2 O, and if there is persistent hypoxemia IPAP and EPAP were increased by 2 cm H 2 O with maximal IPAP limit of 20-25 cm H 2 O and EPAP limit of 10-15 cm H 2 O.
Diagnosis at admission
Ventilation was delivered continuously, with every 4-6 h of continuous NIV; patients had periods of ''rest'' (20-30 min) off the mask while receiving supplemental oxygen, fluids, or dietary liquid supplements with a minimal duration of 16 h per day.
During the weaning phase, with CPAP; patients were weaned from NIV following improvement in respiratory failure by titrating periods off NIV to patient tolerance and objective findings and then removing the ventilator once the pressure is 5 cm H 2 O or less. Patients then received supplemental oxygen by nasal cannula or face mask. While with BIPAP; IPAP was decreased to 7-9 cm H 2 O by decreasing 2-3 cm H 2 O every time based on objective finding, then switching the setting to intermittent use.
Patients received continuous ECG and arterial oxygen saturation monitoring. Patients were examined at regular intervals for abdominal distension and for their ability to clear secretions or to protect the airways. Standard therapy directed toward the etiology of the underlying condition and cause of respiratory failure was maintained during NIV (e.g. patients continued to receive bronchodilator therapy, etc).
The demographic features of patients were recorded, which include age, sex, etiology, type of respiratory failure, performance of the patient, and the presence or absence of associated co-morbid illnesses. We collected the data for arterial blood gases (pH, PaO 2 , FiO 2 , and PaCO 2 ) at baseline, one hour, four hours, and before discharge. The disease severity was calculated using the Acute Physiology and Chronic Health Evaluation (APACHE II) scores. Pneumonia was defined as the presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever greater than 38C, leukocytosis or leukopenia, and purulent secretions) [22] . Microbial confirmation was limited because of the inability to get specimens from the lower respiratory tract by bronchoscopy as it is an invasive procedure. We also recorded patient outcomes, regarding the time spent on NIV, length of ICU stay, length of hospital stay, and patient discharge status. Another complication of NIV is barotrauma, which is defined as the presence of air in the extra-alveolar spaces, such as pneumothorax or pneumomediastinum, due to local overinflation caused by high distending pressure [23] .
Data analysis
Statistical analysis was performed using SPSS version 20. Parametric (t-test) or nonparametric (Mann-Whitney) analysis was used, depending on whether variable distribution was normal or non-normal. Fischer's exact test was applied to the categorical variables due to small expected frequencies, and statistical significance was assumed at a p-value less than Effectiveness of non-invasive ventilation in management of respiratory failure 0.05. Also, regarding ABG data (Ph, PaO 2 , PCO 2 ), multiple analysis of variance (MANOVA) was applied with performance adjusted for multiple comparison.
Results
Over the 10-month period of the study, the number of patients receiving mechanical ventilation with either ETI or NIV in the two medical care units of the An-Najah National University teaching hospital was 86, an average of 2 per week. During that interval, NIV was attempted in 52 cases (60%) that fulfilled the criteria for inclusion and initiation of NIV. It was successful in avoiding intubation in 77% (40/52) of the patients in whom it was attempted and in 47% (40/86) of all patients receiving mechanical ventilation. Most patients in whom NIV was not attempted had received ETI in the emergency department or ward prior to contact by the critical care team because they met the exclusion criteria of this study. The average number of patients attempted on NIV increased from eight per month to 10 per month in the last month. Nine patients received NIV in the cardiac care unit and 43 received it in ICU. The study population was divided into two groups: hypoxemic respiratory failure with a success rate of 78.9% (30/38) and hypercapnic respiratory failure with a success rate of 71.4% (10/14), see Tables 2 and 3 .
The study population had a mean (SD) APACHE II score of 17.81 (7.01) with common indications being weaning from intubation and cardiogenic pulmonary edema, see Table 1 .
NIV with a mean (SD) period of 1.88 (0.983) days was effective in improving physiological parameters throughout the treatment in all except 12 patients, see Table 3 and Figs. 2-4. In Table 4 , although the APACHE scores of the patients who failed NIV were lower (16.9) than those who were successful (18) , this did not reach statistical significance (pvalue = 0.62). The only significant differences observed in baseline characteristics of patients who failed NIV versus those who succeeded are the mean age of the failed group was higher (70) than that in the success group (56) (p-value = 0.036) and the duration of ICU stay was higher (10) in the failed group than in the success group (4) (p-value > 0.001). Of the 12 patients for whom NIV failed, two (4%) patients actually died while mortality rate in the previous meta analysis study was 8% [6] . One of them had multiple comorbid illnesses with a predicted mortality of 42% and died of heart failure and hemodynamic instability; the other patient also had a comorbid illness with a predicted mortality of 21% but died of sudden hypotension due to cardiogenic shock and hemodynamic instability that had no relation to NIV. Also, most of the patients who failed on NIV had a hemodynamic instability (7/12) that occurred during the study, which would meet the exclusion criteria for not initiating the NIV. Reasons for discontinuation of NIV are shown in Table 5 .
The most common problem faced with NIV was air leaks from the masks; this was caused by ill-fitting masks and with the use of appropriately sized masks, it was minimized. Complications of NIV were very rare in this study, occurring only in 2 patients (3.8%), one with excessive secretion and the other with gastric distension that required the insertion of a nasogastric tube. Mask intolerance occurred in 2 patients (3.8%) this result is very low compared to previous studies that report about 30-50% of mask complication [24, 25] . This fact could be due to full time care given to patients by excellently taught nurses.
Neither developed another complication of mechanical ventilation, such as facial skin necrosis, nosocomial pneumonia, (30) or barotrauma. Gastric distention, which occurred once, was not related to the use of higher pressure ventilation, and it was not associated with clinical aspiration; it occurred because the patient had bowel ischemia that happened after initiation of NIV. No serious complications occurred as a result of delaying intubation in patients failing NIV. 
Discussion
The recent increase in the use of NIV in the critical care units has been motivated by the desire to minimize complications of invasive ventilation and to improve resource utilization. The use of NIV in treating of respiratory failure with diverse etiology is now supported by randomized controlled trials and meta-analysis [4] [5] [6] [7] [8] 26] . In these studies, NIV was associated with a reduced need for invasive mechanical ventilation [4, [6] [7] [8] 26] , shortened length of hospital stay [6] , and decreased mortality [5] [6] [7] [8] . Within the context of a prospective observational study, this current study reports a success rate for NIV using CPAP or BIPAP; NIV was successful in 78% of patients. These results are consonant with previously published studies reporting success rates 50-80% with NIV for acute respiratory failure [4] [5] [6] [7] [8] . It is interesting to note that hypoxemic patients formed a significant (73%, N = 38) proportion of patients in our study. Of these, 18 (34%) patients were on NIV to wean from mechanical ventilation, with an 80% success rate, and 15 (29%) patients had cardiogenic pulmonary edema (CPE), with a 76% success rate. NIV was beneficial in patients presenting with CPE in RCTs and meta-analysis studies [7] . While 23% (N = 14) of patients had hypercapnic respiratory failure, with 8 (15%) patients having chronic obstructive pulmonary disease (COPD), diagnosed according to their history, physical examination findings, and pulmonary function tests. High success has been described with NIV in a previous study of patients exhibiting hypercapnic respiratory failure [4] . In a similar study population of hypercapnic patients with a mean baseline of PaCO 2 of 70 mmHg, there was a 74% (32/43) success rate when managed by NIV [4] . It is interesting that 4 (8%) patients in this current study had coexistent obesity that may have contributed to respiratory failure. All of these patients did fine on NIV. Former studies have reported improvements in clinical and biochemical parameters in patients with obesity hypoventilation syndrome [27, 28] . In this study, the clinical improvement of patients on NIV was confirmed by improvements in the physiological variables. There was a significant improvement (P-value > 0.05) in the average PH, PaCO 2 , and PaO 2 levels within hours of application of NIV, see Figs. 2-4. These improvements are similar to those published in a literature in a similar population of patients [4] [5] [6] [7] [8] . The severity of illness at presentation, as displayed by the APACHE ll score, is postulated to influence response to NIV. Although two studies [29, 30] , demonstrated propensity for failure with NIV in patients with higher APACHE ll scores, this observation has not been supported by other studies [31, 32] . The mean (SD) APACHE ll score in the current study was 17.81 (7.01). Although the mean APACHE ll scores were higher between responders (18.075) compared to non responders (16.916), this difference was not statistically significant (P = 0.62). The tendency toward a longer duration of hospitalization in patients for whom NIV failed in the current study, compared to those who were treated successfully, may be due to early deaths in those who failed NIV. This was not statistically significant (P = 0.077), but ICU stay was (P = 0.001); patients for whom NIV failed had a longer duration of ICU stay than those for whom NIV was successful.
The duration of NIV in hypoxemic respiratory failure patients with mean (SD) period was 1.92 (1.02) days which represents the same result as previous studies [23, 33] . While the duration in hypercapnic with mean (SD) period was 1.79 (0.9), which is longer than the previous study of mean 26 h [34] . Regarding etiology of NIV the longer duration for community acquired pneumonia with mean (SD) period was 2.88 (1.6) , which is the same as other study [35] . And shorter duration for obesity/hypoventilation syndrome with mean (SD) period was 1.3 (0.6), see Table 2 . NIV aims to eliminate the complications of invasive MV, such as ventilator-associated pneumonia (VAP) and barotrauma. VAP rates are high in patients put on MV, with 8-28% of patients developing this problem [36] , and about 21.6% here in Palestine in 2013 [37] . No patients in our study revealed a new infiltration on the X-ray associated with fever, tachypnea, or leucocytosis that could suggest nosocomial pneumonia.
The findings of this prospective observational study confirm other previous reports on the effectiveness of NIV in managing patients with respiratory failure. However, this study did not evaluate determinants of success of NIV (such as level of consciousness, BMI, hemodynamic state, respiratory rate, etc.), which could be considered a limitation. However, it is worthwhile to mention that the functional status before respiratory failure was much better in the NIV responder group compared with NIV nonresponders. The same thing was observed with regard to comorbidities, which were higher in NIV nonresponders than in NIV responders; this could be used to predict the failure or success of NIV. Despite these limitations, this study has demonstrated that NIV is not only a feasible ventilatory modality in Palestine, but is also a treatment that is correlated with significant improvements in physiological and clinical outcomes. The application of NIV resulted in low rates of endotracheal intubation and fewer complications, and was well tolerated in our study population, although a cost-benefit analysis would have granted a credit to NIV use in Middle Eastern countries, especially ours. The lower cost of non-invasive ventilators (compared to standard invasive ventilators), reduced length of stay in the hospital, and lower complication rates are likely to translate to desirable economic benefits, although further studies with larger sample sizes are needed to prove that.
Further implications regarding the use of NIV need to be addressed in the context of the Ministry of Health of Palestine. Newer modalities of treatment, such as NIV, demand trained teams that can not only implement such therapies, but also allow such treatments to translate to improvements in patient and clinical outcomes. I was fortunate to have a critical care specialist who obtained skills in NIV abroad and who consequently trained the devoted medical and nursing teams and the respiratory therapists on the use of NIV and supervised patient care. Within a few months, NIV became an indispensable part of the respiratory support of the A-Najah National University teaching hospital's two care units. NIV has become the preferred initial treatment of patients with hypercapnic respiratory failure and in those with hypoxemic respiratory failure in whom the clinical condition can be readily reversed (48-72 h), when airway control is not needed, and the patient is hemodynamically and electrocardiographically stable.
Also, it is worth to mention that this can be achieved without any increase in the nursing and technical staff that looks after such patients. Also, there was no additional cost of buying dedicated non-invasive ventilators, because the modern ventilators can be used for both invasive and non-invasive ventilation. It would be interesting to evaluate, in future studies, factors that can predict the success or failure of NIV, or study the effectiveness of NIV in a particular type of respiratory failure (like type 1, type 2, COPD, CPE, obesity, etc.) as this mode of treatment could gain wide acceptance as a primary technique of treatment in the region for patients exhibiting respiratory failure.
